Chloe Dygert revealed that she recently underwent a procedure to treat heart arrhythmia. The U.S. Olympic medalist confirmed doctors carried out a cardiac ablation to treat supraventricular ...

Deltona, Fla.-based Advanced Heart and Vascular Surgery Center, an affiliate of Cardiovascular Centers of America, has become the first ASC in Florida to launch a complete cardiac ablation service ...

London, United Kingdom – 1 September 2024: Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the ...

BOSTON -- For persistent atrial fibrillation (Afib), adding artificial intelligence guidance for ablation site selection improved success, the TAILORED trial showed. Freedom from Afib after one ...

Loyola Medicine is the only center in the Midwest enrolling patients in a landmark clinical trial of a new procedure to treat a life-threatening heart rhythm disorder called ventricular tachycardia.

Amman, Oct. 29 (Petra) -- A specialized medical team at Prince Hamzah Hospital has achieved a significant milestone by successfully performing Jordan's first cardiac ablation procedures to treat ...

Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the current most widely used technique, ...

AI-Guided Cardiac Ablation in combination with pulmonary vein isolation was superior to the standard of care in the treatment of Persistent Atrial Fibrillation Volta Medical Announces Publication of ...

Heart arrhythmias are usually harmless, but some can be life threatening. Treatments help correct your heart rate to prevent serious health issues. When the electrical impulses that affect your ...

A study found that undergoing a cardiac ablation procedure first—before taking any antiarrhythmic therapies—may be the better option for people who have developed a dangerous rhythm after surviving a ...

Berlin, Germany – 8 April 2024: The first randomised trial to investigate preventive ablation of a potential arrhythmogenic substrate associated with coronary chronic total occlusion (CTO) in patients ...